4//SEC Filing
Yoo Stephen 4
Accession 0001562180-18-004642
CIK 0001590877other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:21 PM ET
Size
20.0 KB
Accession
0001562180-18-004642
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Yoo Stephen
Chief Medical Officer
Transactions
- Sale
Common Stock
2018-11-19$63.21/sh−1,100$69,531→ 0 total - Exercise/Conversion
Common Stock
2018-11-19$0.85/sh+20,414$17,352→ 20,414 total - Sale
Common Stock
2018-11-19$61.55/sh−800$49,240→ 1,100 total - Sale
Common Stock
2018-11-19$58.37/sh−2,300$134,251→ 15,353 total - Sale
Common Stock
2018-11-19$60.25/sh−4,361$262,750→ 1,900 total - Sale
Common Stock
2018-11-19$57.08/sh−2,761$157,598→ 17,653 total - Sale
Common Stock
2018-11-19$59.61/sh−9,092$541,974→ 6,261 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-19−20,414→ 61,244 totalExercise: $0.85Exp: 2024-11-03→ Common Stock (20,414 underlying)
Footnotes (8)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $56.79 to $57.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $57.90 to $58.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $58.91 to $59.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $59.93 to $60.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $61.02 to $61.845. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $62.80 to $63.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]The previously granted option, representing a right to purchase a total of 247,900 shares, became exercisable as follows: 165,200 of the shares subject to the option are initial shares ("Initial Shares") and 82,700 of the shares subject to the option are contingent shares ("Contingent Shares"). 23,600 of the Initial Shares vested on October 13, 2014, 35,400 of the Initial Shares vested on October 13, 2015 and an additional 2,950 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 15% of the Contingent Shares were deemed vested as of October 13, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following October 13, 2014, with 25% of the remaining 85% of Contingent Shares having vested on October 13, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001652825
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 4:21 PM ET
- Size
- 20.0 KB